Hao Zhou1, Minjia Yu1, Junjie Zhao1, Bradley N Martin1, Sanjoy Roychowdhury2, Megan R McMullen2, Emily Wang1, Paul L Fox3, Sho Yamasaki4, Laura E Nagy2,5, Xiaoxia Li1. 1. Department of Immunology, Cleveland Clinic, Cleveland, OH. 2. Center for Liver Disease Research, Department of Pathobiology, Cleveland Clinic, Cleveland, OH. 3. Department of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, OH. 4. Division of Molecular Immunology, Research Center for Infectious Diseases, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan. 5. Department of Gastroenterology, Cleveland Clinic, Cleveland, OH.
Abstract
Lipopolysaccharide (LPS)-mediated activation of Toll-like receptors (TLRs) in hepatic macrophages and injury to hepatocytes are major contributors to the pathogenesis of alcoholic liver disease. However, the mechanisms by which TLR-dependent inflammatory responses and alcohol-induced hepatocellular damage coordinately lead to alcoholic liver disease are not completely understood. In this study, we found that mice deficient in interleukin-1 receptor-associated kinase M (IRAKM), a proximal TLR pathway molecule typically associated with inhibition of TLR signaling, were actually protected from chronic ethanol-induced liver injury. In bone marrow-derived macrophages challenged with low concentrations of LPS, which reflect the relevant pathophysiological levels of LPS in both alcoholic patients and ethanol-fed mice, the IRAKM Myddosome was preferentially formed. Further, the IRAKM Myddosome mediated the up-regulation of Mincle, a sensor for cell death. Mincle-deficient mice were also protected from ethanol-induced liver injury. The endogenous Mincle ligand spliceosome-associated protein 130 (SAP130) is a danger signal released by damaged cells; culture of hepatocytes with ethanol increased the release of SAP130. Ex vivo studies in bone marrow-derived macrophages suggested that SAP130 and LPS synergistically activated inflammatory responses, including inflammasome activation. CONCLUSION: This study reveals a novel IRAKM-Mincle axis that contributes to the pathogenesis of ethanol-induced liver injury. (Hepatology 2016;64:1978-1993).
Lipopolysaccharide (LPS)-mediated activation of Toll-like receptors (TLRs) in hepatic macrophages and injury to hepatocytes are major contributors to the pathogenesis of alcoholic liver disease. However, the mechanisms by which TLR-dependent inflammatory responses and alcohol-induced hepatocellular damage coordinately lead to alcoholic liver disease are not completely understood. In this study, we found that mice deficient in interleukin-1 receptor-associated kinase M (IRAKM), a proximal TLR pathway molecule typically associated with inhibition of TLR signaling, were actually protected from chronic ethanol-induced liver injury. In bone marrow-derived macrophages challenged with low concentrations of LPS, which reflect the relevant pathophysiological levels of LPS in both alcoholic patients and ethanol-fed mice, the IRAKM Myddosome was preferentially formed. Further, the IRAKM Myddosome mediated the up-regulation of Mincle, a sensor for cell death. Mincle-deficient mice were also protected from ethanol-induced liver injury. The endogenous Mincle ligand spliceosome-associated protein 130 (SAP130) is a danger signal released by damaged cells; culture of hepatocytes with ethanol increased the release of SAP130. Ex vivo studies in bone marrow-derived macrophages suggested that SAP130 and LPS synergistically activated inflammatory responses, including inflammasome activation. CONCLUSION: This study reveals a novel IRAKM-Mincle axis that contributes to the pathogenesis of ethanol-induced liver injury. (Hepatology 2016;64:1978-1993).
Authors: Koichi Kobayashi; Lorraine D Hernandez; Jorge E Galán; Charles A Janeway; Ruslan Medzhitov; Richard A Flavell Journal: Cell Date: 2002-07-26 Impact factor: 41.582
Authors: Christine A Wells; Judith A Salvage-Jones; Xin Li; Kelly Hitchens; Suzanne Butcher; Rachael Z Murray; Anthony G Beckhouse; Yu-Lan-Sandra Lo; Silvia Manzanero; Christian Cobbold; Kate Schroder; Bo Ma; Sally Orr; Lauren Stewart; Daniel Lebus; Peter Sobieszczuk; David A Hume; Jennifer Stow; Helen Blanchard; Robert B Ashman Journal: J Immunol Date: 2008-06-01 Impact factor: 5.422
Authors: Dominikus Strasser; Konstantin Neumann; Hanna Bergmann; Mohlopheni J Marakalala; Reto Guler; Anna Rojowska; Karl-Peter Hopfner; Frank Brombacher; Henning Urlaub; Gottfried Baier; Gordon D Brown; Michael Leitges; Jürgen Ruland Journal: Immunity Date: 2012-01-27 Impact factor: 31.745
Authors: Kevin Shenderov; Daniel L Barber; Katrin D Mayer-Barber; Sudagar S Gurcha; Dragana Jankovic; Carl G Feng; Sandy Oland; Sara Hieny; Pat Caspar; Sho Yamasaki; Xin Lin; Jenny P-Y Ting; Giorgio Trinchieri; Gurdyal S Besra; Vincenzo Cerundolo; Alan Sher Journal: J Immunol Date: 2013-04-29 Impact factor: 5.422
Authors: Hadar Feinberg; Sabine A F Jégouzo; Thomas J W Rowntree; Yue Guan; Matthew A Brash; Maureen E Taylor; William I Weis; Kurt Drickamer Journal: J Biol Chem Date: 2013-08-19 Impact factor: 5.157
Authors: Hao Zhou; Minja Yu; Sanjoy Roychowdhury; Carlos Sanz-Garcia; Katherine A Pollard; Megan R McMullen; Xiuli Liu; Xiaoxia Li; Laura E Nagy Journal: Alcohol Clin Exp Res Date: 2017-03-10 Impact factor: 3.455
Authors: Bryony Braschi; Ruth L Seal; Susan Tweedie; Tamsin E M Jones; Elspeth A Bruford Journal: Am J Hum Genet Date: 2021-10-07 Impact factor: 11.025
Authors: Suheyla Hasgur; Yosuke Yamamoto; Ran Fan; Michael Nicosia; Victoria Gorbacheva; Daniel Zwick; Motoo Araki; Robert L Fairchild; Anna Valujskikh Journal: Am J Transplant Date: 2022-04-01 Impact factor: 9.369